Elutia Inc. (ELUT) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $1.15
• Market Cap: $46.54M
• EPS: $-0.93
• 52-Week High: $3.46
• 52-Week Low: $0.50

Market Sentiment

Elutia Inc. currently has a Neutral sentiment score of 0.02.

About Elutia Inc.

Elutia Inc. is a forward-thinking commercial-stage biotechnology company headquartered in Silver Spring, Maryland, dedicated to revolutionizing surgical outcomes through its innovative drug-eluting biomatrix technologies. With a strong emphasis on addressing pressing unmet medical needs, Elutia's technologies stand to redefine traditional surgical practices, positioning the company as a key player in the biopharmaceutical sector. As it continues to advance its pipeline and drive breakthroughs...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Elutia Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ELUT pay dividends?

Elutia Inc. (ELUT) does not currently pay a regular dividend.

What is ELUT's market cap?

Elutia Inc. (ELUT) has a market capitalization of $46.54M with a current stock price of $1.15.